AI assistant
Sending…
GERON CORP — Director's Dealing 2011
Feb 11, 2011
32370_dirs_2011-02-11_2aa749bd-956a-4484-af45-cbd5bda00cfe.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 5 — Annual Statement of Changes in Beneficial Ownership
Issuer: GERON CORP (GERN)
CIK: 0000886744
Period of Report: 2010-12-31
Reporting Person: Kelsey Stephen Michael (EVP, CMO, Oncology)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2010-12-31 | Common Stock | A | 2158 | $4.11 | Acquired | 378294 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 3136 | Indirect |
Footnotes
F1: Represents shares held under Geron 401(k) Plan. In January 2011, the reporting person acquired 3,136 shares of Geron common stock under the Geron 401(k) plan.
F2: Shares acquired under the Company's 1996 Employee Stock Purchase Plan.
More from GERON CORP
Regulatory Filings
2026
May 27
Major Shareholding Notification
2026
May 8
Interim / Quarterly Report
2026
May 6
Annual Report
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 26
Director's Dealing
2026
Mar 26
Director's Dealing
2026
Mar 26